APLT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead the Applied Therapeutics Class Action Lawsuit
Portfolio Pulse from
Robbins Geller Rudman & Dowd LLP has announced a class action lawsuit against Applied Therapeutics, Inc. (NASDAQ: APLT) for alleged violations of the Securities Exchange Act of 1934. Investors who purchased APLT securities between January 3, 2024, and December 2, 2024, have until February 18, 2025, to seek lead plaintiff status.
December 18, 2024 | 9:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Applied Therapeutics, Inc. is facing a class action lawsuit for alleged violations of the Securities Exchange Act of 1934. This legal action could impact the company's stock price negatively in the short term.
The announcement of a class action lawsuit against Applied Therapeutics for alleged securities violations is likely to create uncertainty and negative sentiment among investors, potentially leading to a short-term decline in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100